miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling

por Mazzu, Ying Z., Hu, Yulan, Shen, Yawei, Tuschl, Thomas, Singer, Samuel
Publicado 2019

Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer

por Mazzu, Ying Z., Yoshikawa, Yuki, Nandakumar, Subhiksha, Chakraborty, Goutam, Armenia, Joshua, Jehane, Lina E., Lee, Gwo‐Shu Mary, Kantoff, Philip W.
Publicado 2019

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

por Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, Gwo‐Shu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.
Publicado 2020

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

por Mazzu, Ying Z., Liao, YuRou, Nandakumar, Subhiksha, Sjöström, Martin, Jehane, Lina E., Ghale, Romina, Govindarajan, Barani, Gerke, Travis A., Lee, Gwo‐Shu Mary, Luo, Jian‐Hua, Chinni, Sreenivasa R., Mucci, Lorelei A., Feng, Felix Y., Kantoff, Philip W.
Publicado 2022

Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer

por Mazzu, Ying Z., Liao, Yu-Rou, Nandakumar, Subhiksha, Jehane, Lina E., Koche, Richard P., Rajanala, Sai Harisha, Li, Ruifang, Zhao, HuiYong, Gerke, Travis A., Chakraborty, Goutam, Lee, Gwo-Shu Mary, Nanjangud, Gouri J., Gopalan, Anuradha, Chen, Yu, Kantoff, Philip W.
Publicado 2022

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer

por Yoshikawa, Yuki, Stopsack, Konrad H., Wang, Xin Victoria, Chen, Yu‐Hui, Mazzu, Ying Z., Burton, Foster, Chakraborty, Goutam, Rajanala, Sai Harisha, Hirani, Rahim, Nandakumar, Subhiksha, Lee, Gwo‐Shu Mary, Frank, David, Davicioni, Elai, Liu, Glenn, Carducci, Michael A., Azuma, Haruhito, Kantoff, Philip W., Sweeney, Christopher J.
Publicado 2022